• Issue

    Cancer Medicine: Volume 14, Issue 5

    March 2025

ISSUE INFORMATION

Open Access

Issue Information

  • First Published: 27 February 2025

RESEARCH ARTICLE

Open Access

A highly sensitive screening system to evaluate the reversibility of neuroendocrine prostate cancer to prostate adenocarcinoma

  • First Published: 27 February 2025
A highly sensitive screening system to evaluate the reversibility of neuroendocrine prostate cancer to prostate adenocarcinoma

We established a robust and sensitive androgen response element luciferase reporter assay to monitor androgen receptor (AR) activity using KUCaP13 cells, a novel human-derived treatment-related neuroendocrine prostate cancer (t-NEPC) cell line. A high-throughput screening using a chemical library to identify potential compounds that induce AR re-expression in KUCaP13 cells revealed 30 candidate molecules potentially enhancing luciferase luminescence; however, subsequent validation steps demonstrated these signals to be false-positives. Despite not achieving the goal of AR re-expression, this study stands as a significant proof-of-concept for the application of high-throughput screening approaches in t-NEPC research.

METHOD

Open Access

Study Protocol of a Prospective Phase 2 Study of Chlorophyllin for the Management of Brain Radionecrosis in Patients With Diffuse Glioma (CHROME)

  • First Published: 02 March 2025
Study Protocol of a Prospective Phase 2 Study of Chlorophyllin for the Management of Brain Radionecrosis in Patients With Diffuse Glioma (CHROME)

Chlorophyllin is an orally administered phytopharmaceutical that has anti-inflammatory effects. In the current phase 2 study, the efficacy of CHL will be investigated in both symptomatic and asymptomatic radionecrosis, with clinico-radiological response at 1 month as the primary endpoint.

RESEARCH ARTICLE

Open Access

Efficacy of the PanCareFollowUp eHealth Lifestyle Intervention for Survivors of Childhood, Adolescent and Young Adult Cancer

  • First Published: 28 February 2025
Efficacy of the PanCareFollowUp eHealth Lifestyle Intervention for Survivors of Childhood, Adolescent and Young Adult Cancer

Within the European PanCareFollowUp project, an eHealth lifestyle intervention was developed to guide survivors of childhood, adolescent and young adult cancer in adopting healthier behaviours. Results from this efficacy analysis are positive and can be used for further study and implementation.

Open Access

Utility of a Large Series of B-Cell Precursor Acute Lymphoblastic Leukemia Cell Lines as a Model System

  • First Published: 01 March 2025
Utility of a Large Series of B-Cell Precursor Acute Lymphoblastic Leukemia Cell Lines as a Model System

RNA sequencing in a large series of B-cell precursor acute lymphoblastic leukemia cell lines was performed. Using the data, a close association between types of fusion genes and patterns of gene expression was demonstrated. Furthermore, several cell cycle-related genes that were correlated with cell cycle progression and relapsed-related genes that were associated with disease relapse in the clinical samples were identified.

Open Access

Transparency and Representation in Clinical Research Utilizing Artificial Intelligence in Oncology: A Scoping Review

  • First Published: 09 March 2025
Transparency and Representation in Clinical Research Utilizing Artificial Intelligence in Oncology: A Scoping Review

A minority of oncologic studies utilizing AI analyzed in this review reported the racial and ethnic demographic data of participants included in their training and validation sets. In studies that did report racial demographic data, few non-white patients were included in the datasets.

Open Access

Bone Metastasis Mediates Poor Prognosis in Early-Onset Gastric Cancer: Insights Into Immune Suppression, Coagulopathy, and Inflammation

  • First Published: 05 March 2025
Bone Metastasis Mediates Poor Prognosis in Early-Onset Gastric Cancer: Insights Into Immune Suppression, Coagulopathy, and Inflammation

This study highlights the significant impact of bone metastasis on the prognosis of early-onset gastric cancer (EOGC). Patients with bone metastasis exhibit a unique pathological profile characterized by immune suppression, inflammatory activation, and coagulation imbalances, creating an environment that promotes tumor progression. Key findings include elevated pro-inflammatory cytokines and coagulation markers, emphasizing the need for targeted therapeutic strategies to improve outcomes in bone metastatic early-onset gastric cancer patients.

Open Access

Associations of Social Vulnerability and Race-Ethnicity With Gastrointestinal Cancers in the United States

  • First Published: 05 March 2025

This social determinant of health (SDoH) study on 287,248 adult GIC-patients showed worse multimodal treatment receipt and survival with increasing overall social vulnerability as measured by the Social Vulnerability Index (SVI) while quantifiably delineating which SDoH contribute more to GIC-disparities.

image

Open Access

Mono-TKI and TKI Plus ICI in Unresectable Hepatocellular Carcinoma Progression on First-Line Treatment of Lenvatinib: A Real-World Study

  • First Published: 06 March 2025
Mono-TKI and TKI Plus ICI in Unresectable Hepatocellular Carcinoma Progression on First-Line Treatment of Lenvatinib: A Real-World Study

The combination of TKI and ICI for uHCC after LEN failure demonstrated great survival benefits and was well tolerated, irrespective of the second-line TKI administered.

Open Access

Prognostic Value of Trop-2 Expression in Nonmetastatic Triple-Negative Breast Cancer and Correlation With Emerging Biomarkers

  • First Published: 10 March 2025
Prognostic Value of Trop-2 Expression in Nonmetastatic Triple-Negative Breast Cancer and Correlation With Emerging Biomarkers

Because Trop-2 ADC targeting is highly promising in TNBC, we aimed at clarifying Trop-2 expression clinicopathological correlations. Trop-2 protein expression appeared nearly constant in TNBC, independent of classical risk variables and outcome. This is favorable to multiple therapeutic associations of anti-Trop-2 ADC with other drugs and avoids splintering the patient population in subclasses.

Open Access

Predicting Neoplastic Polyp in Patients With Gallbladder Polyps Using Interpretable Machine Learning Models: Retrospective Cohort Study

  • First Published: 07 March 2025
Predicting Neoplastic Polyp in Patients With Gallbladder Polyps Using Interpretable Machine Learning Models: Retrospective Cohort Study

This study presents a novel and interpretable approach to accurately predicting the neoplastic nature of gallbladder polyps (GBPs). We developed and validated interpretable machine learning (ML) models using data from 924 patients with GBPs who underwent cholecystectomy. Nine ML algorithms were employed, with the K-nearest neighbors, C5.0 decision tree algorithm and gradient boosting machine models demonstrating the highest predictive efficacy for neoplastic polyps.

Open Access

Mediators of Racial Inequities in Non-Small Cell Lung Cancer Care

  • First Published: 07 March 2025
Mediators of Racial Inequities in Non-Small Cell Lung Cancer Care

Individual- and neighborhood-level factors mediate the observed racial inequities in the quality of non-small cell lung cancer (NSCLC) care, and their effects vary based on the phase of cancer care. The design of interventions addressing these structural drivers of inequitable care should be tailored based on the phase of NSCLC care.

Open Access

Statin Drugs Are Associated With Response to Immune Checkpoint Blockade in Recurrent/Metastatic Head and Neck Cancer

  • First Published: 07 March 2025
Statin Drugs Are Associated With Response to Immune Checkpoint Blockade in Recurrent/Metastatic Head and Neck Cancer

Cholesterol manipulation has recently been associated with enhanced responses to immunotherapy. Review of clinical outcomes among patients treated with immune checkpoint blockade for head and neck cancer at our institution shows that statin use was independently associated with an objective response, but no significant increase in survival.

RESEARCH ARTICLE

Open Access

Radiation-Enhanced AF1q Moves Center Stage as a Key Driver to Favorable Tumor Stage in Rectal Cancer Patients

  • First Published: 10 March 2025
Radiation-Enhanced AF1q Moves Center Stage as a Key Driver to Favorable Tumor Stage in Rectal Cancer Patients

Short-term radiation therapy induces oncogenic AF1q expression in rectal cancer that correlates with negative lymph node stage AF1q expression associates with high STAT1 and low IDO1 expression in irradiated tumor samples The favorable effects of short-term radiation therapy on tumor biology might be enhanced by an AF1q-driven pro-apoptotic signaling axis AF1q may be a promising therapeutic target responsive to radiation therapy.

RESEARCH ARTICLE

Open Access

Arid4a Suppresses Breast Tumor Metastasis by Enhancing MTSS1 Expression via mRNA Stability

  • First Published: 11 March 2025
Arid4a Suppresses Breast Tumor Metastasis by Enhancing MTSS1 Expression via mRNA Stability

Here, we identified the low expression pattern of RNA-binding protein Arid4a in human breast cancers and its potential role in modulating tumor metastasis-related gene expression and tumor progression. Mechanistically, Arid4a could upregulate the expression of metastasis-suppressing genes by stabilizing their mRNAs via binding to the stem–loop structure localized in 3′ UTR.

RESEARCH ARTICLE

Open Access

Evaluating Clinical and Sociodemographic Risk for Symptom Burden Associated Interference With Daily Functioning in the Primary Brain Tumor Patient Population

  • First Published: 07 March 2025
Evaluating Clinical and Sociodemographic Risk for Symptom Burden Associated Interference With Daily Functioning in the Primary Brain Tumor Patient Population

Activity and mood-related interference is common in primary brain tumor patients. Severity is associated with both clinical factors (diagnosis, number of surgeries) and social determinants of health (rural disparities).